Stocksigma LogoStocksigma Logo

Welcure Drugs Reports Q3 FY26 Results; Profit After Tax Reaches ₹106.67 Lakhs

Welcure Drugs and Pharmaceuticals reported unaudited financial results for Q3 FY26, posting a profit after tax of ₹106.67 lakhs

Welcure Drugs Reports Q3 FY26 Results; Profit After Tax Reaches ₹106.67 Lakhs

Welcure Drugs & Pharmaceuticals Ltd · Financial Result · 13 Feb 2026, 1:06 am

Welcure Drugs Reports Q3 FY26 Results; Profit After Tax Reaches ₹106.67 Lakhs Welcure Drugs and Pharmaceuticals reported unaudited financial results for Q3 FY26, posting a profit after tax of ₹106.67 lakhs. Total income for the quarter ended 31st Dec’25 stood at ₹146.43 lakhs, a significant QoQ decline from ₹6,562.40 lakhs. However, PAT grew 157% YoY from ₹41.50 lakhs. Profit before tax was ₹142.55 lakhs. The auditor's limited review report included a disclaimer of opinion, noting an inability to obtain sufficient evidence for their conclusion on the financial statements.

Original exchange filing (PDF)

More announcements from Welcure Drugs & Pharmaceuticals Ltd

All Welcure Drugs & Pharmaceuticals Ltd announcements